Docsity
Docsity

Prepara tus exámenes
Prepara tus exámenes

Prepara tus exámenes y mejora tus resultados gracias a la gran cantidad de recursos disponibles en Docsity


Consigue puntos base para descargar
Consigue puntos base para descargar

Gana puntos ayudando a otros estudiantes o consíguelos activando un Plan Premium


Orientación Universidad
Orientación Universidad


epiescleritis oftalmo, escleritis, Apuntes de Oftalmología

escleritis, epiesclerites area de medicina oftalmoscopia

Tipo: Apuntes

2019/2020

Subido el 11/04/2020

nestor53
nestor53 🇲🇽

1 documento

1 / 3

Toggle sidebar

Esta página no es visible en la vista previa

¡No te pierdas las partes importantes!

bg1
202 External Disease and Cornea
Tolerance
of
a corneal graft
is
now recognized
as
an active process based on several
features:
absence of blood and lymphatic channels in
the
graft and its bed
absence
of
MHC class II+ APCs in the graft
reduced expression ofMHC-encoded alloantigens on graft
cells
replaced with minor
peptides (nonclassical MHC-Ib molecules) to avoid lysis
by
natural killer cells
expression
ofT
-c
ell
-deleting CD95 ligand (Fas ligand, or
FasL)
on endothelium,
which can induce apoptosis in killer T cells
Pooyan
6696
1
526-7
immunosuppressive microenvironment of
the
aqueous humor, including trans-
forming growth factor
~
2
,
a-melanocyte-stimulating hormone, vasoactive intesti-
nal peptide, and calcitonin gene-related peptide
anterior chamber-associated immune deviation (ACAID) involving the develop-
ment
of
suppressor T cells (ACAID
is
a downregulation of delayed-type cellular im-
munity. Antigens released into the aqueous
humor
are, presumably, recognized by
dendritic cells of the iris and ciliary body. These APCs can then enter venous circu-
lation and induce regulatory T cells in the spleen, bypassing the lymphatic system.)
For an immune response to occur, an antigenic substance
is
introduced and "recog-
nized" (afferent limb), producing the synthesis of specific antibody molecules and the
appearance
of
effector lymphocytes that react specifically with the immunizing antigen
(efferent limb). Although antibodies to foreign tissues are formed during graft rejection,
they are not believed
to
be important in the usual type of allograft rejection. Rather, exten-
sive evidence indicates that allograft rejection
is
associated with cellular immune mech-
anisms. The term delayed hypersensitivity, or type
TV,
reaction
is
used to describe such
T-lymphocyte-mediated responses. Other mechanisms are also probably involved. For
the endothelial cells to be rejected, they must express MHC class II antigens. Streilein sug-
gests that in the presence of inflammatory stress (including mediators
TNF-a
and IFN-y),
the endothelial cells' endogenous minor H antigens, which are recognized by the CD4+
T cells,
le
ad to delayed hypersensitivity and graft rejection.
See
also the discussion
of
clinical signs
of
corneal transplant rejection in Chapter
15
of
this
vo
lume.
BCSC
Section 9, Intraocu lar Inflammation and Uveitis, discusses and
il
-
lustrates the principles of immunology in greater detail.
Bachmann
B,
Taylor
RS,
Cursiefen
C.
Corneal neovasculari
za
tion
as
a risk factor for graft
failure
and
rejection
af
ter keratoplasty: an evidence-based meta-analysis. Ophthalmology.
2010;
11
7(7):1300-l305.e7.
Niederkorn
JY.
Cornea: window to ocular immunology. Curr
lm
mun
ol
Rev.
2011;7(3):
328-335.
Immune-M
ediated
Diseases
of
the
Epi
sc
lera
and
Sclera
Episcleritis
PATHOGENESIS Episcleritis
is
a self-limited,
ge
nerally benign inflammation
of
the episcleral
tissues. An underlying systemic cause
is
found in only a minority of patients.
pf3

Vista previa parcial del texto

¡Descarga epiescleritis oftalmo, escleritis y más Apuntes en PDF de Oftalmología solo en Docsity!

202 • External Disease and Cornea

Tolerance of a corneal graft is now recognized as an active process based on several features:

  • absence of blood and lymphatic channels in the graft and its bed
  • absence of MHC class II+ APCs in the graft
  • reduced expression ofMHC-encoded alloantigens on graft cells replaced with minor peptides (nonclassical MHC-Ib molecules) to avoid lysis by natural killer cells
  • expression ofT-c ell - deleting CD95 ligand (Fas ligand, or FasL) on endothelium, which can induce apoptosis in killer T cells Pooyan 6696 1 526-
  • immunosuppressive microenvironment of the aqueous humor, including trans- forming growth factor ~ 2 , a -melanocyte-stimulating hormone, vasoactive intesti- nal peptide, and calcitonin gene-related peptide
  • anterior chamber- associated immune deviation (ACAID) involving the develop- ment of suppressor T cells (ACAID is a downregulation of delayed-type cellular im- munity. Antigens released into the aqueous humor are, presumably, recognized by dendritic cells of the iris and ciliary body. These APCs can then enter venous circu- lation and induce regulatory T cells in the spleen, bypassing the lymphatic system.) For an immune response to occur, an antigenic substance is introduced and "recog- nized" (afferent limb), producing the synthesis of specific antibody molecules and the appearance of effector lymphocytes that react specifically with the immunizing antigen (efferent limb). Although antibodies to foreign tissues are formed during graft rejection, they are not believed to be important in the usual type of allograft rejection. Rather, exten- sive evidence indicates that allograft rejection is associated with cellular immune mech- anisms. The term delayed hypersensitivity, or type TV, reaction is used to describe such T-lymphocyte-mediated responses. Other mechanisms are also probably involved. For the endothelial cells to be rejected, they must express MHC class II antigens. Streilein sug- gests that in the presence of inflammatory stress (including mediators TNF-a and IFN-y), the endothelial cells' endogenous minor H antigens, which are recognized by the CD4+ T cells, le ad to delayed hypersensitivity and graft rejection. See also the discussion of clinical signs of corneal transplant rejection in Chapter 15 of this vo lume. BCSC Section 9, Intraocular Inflammation and Uveitis, discusses and il - lustrates the principles of immunology in greater detail.

Bachmann B, Taylor RS, Cursiefen C. Corneal neovasculari za tion as a risk factor for graft failure and rejection after keratoplasty: an evidence-based meta-analysis. Ophthalmology. 2010; 11 7(7):1300- l 305.e7. Niederkorn JY. Cornea: window to ocular immunology. Curr lm mun ol Rev. 2011;7(3): 328- 335.

Immune-M ediated Diseases of the Epi sc lera and Sclera

Episcleritis

PATHOGENESIS Episcleritis is a self-limited, ge nerally benign inflammation of the episcleral tissues. An underlying systemic cause is found in only a minority of patients.

CHAPTER 7: Immune -Related Disorders of the External Eye • 203

CLINICAL PRESENTATION Episcleritis is typically a sudden-onset, transient (usually days to weeks), self-limited disease affecting adults aged 20-50 years, with most cases occurring in women. The chief complaint is usually ocular redness without irritation, which resolves spontaneously. Slight tenderness may be present. The disease occurs most commonly in the exposed interpalpebral zone of the eye, often in the area of a pinguecula. It may recur in the same or different locations. About one-third of patients have bilateral disease at one time or another. Episcleritis is diagnosed clinically by attributing the inflammation to the level of the episclera. It must be differentiated from the deeper inflammation seen in scleritis (often with associated scleral edema clearly discernible on slit-lamp examination). Episcleral in- flammation is superficial. The deep pain of scleritis is absent in episcleritis. The character- istic color in episcleritis is bright red or salmon pink in natural light, unlike the violaceous hue seen in most forms of scleritis. In addition, the redness in episcleritis (unlike that associated with scleritis) will blanch with application of2.5% topical phenylephrine. Episcleritis is classified as simple (diffuse injection) or nodular. In simple episcleri- tis, the inflammation is localized to a sector of the globe in 70% of cases and to the en- tire episclera in 30% of cases. A localized mobile nodule develops in nodular episcleritis (Fig 7-20). Small peripheral corneal opacities can be observed adjacent to the area of epi- scleral inflammation in 10% of patients. The disease generally resolves without producing any lasting destructive effects on tissues of the eye.

MANAGEMENT A workup for underlying causes ( eg, autoimmune connective tissue disease such as Sjogren syndrome or rheumatoid arthritis; other conditions such as gout, her- pes zoster, syphilis, tuberculosis, Lyme disease, or rosacea) is rarely indicated except after multiple recurrences. Episcleritis generally clears without treatment, but topical or oral NSAIDs may be prescribed for patients bothered by the pain. Most patients simply need reassurance that their condition is not sight threatening and can be treated with lubricants

Figure 7-20 Nodular episcleritis.